This image gallery shows what the various clinical presentations associated with the COVID-19 and long COVID that have been documented during and after coronavirus pandemic.
Amid work-from-home disparities between interventional and diagnostic rads, researchers recently interviewed hundreds of IRs to learn about the landscape.
The program creates a network of accredited sites where radiation oncologists can complete the final regulatory requirements needed to become authorized users for RPT.
Both recalls are categorized as Class 2, which the FDA designates for issues that have the potential to “cause temporary or medically reversible adverse health consequences."